next generation nucleic acid polymers (REPLICor)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namenext generation nucleic acid polymers (REPLICor)
Drug Alias NameREP-2163REP-006REP-2053REP-2031REP-2166
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis DHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReplicor Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReplicor Inc
Active IndicationsN/A
Inactive IndicationsHepatitis DHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A